1. Adelaide Research & Scholarship

Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 18 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Common variants in mendelian kidney disease genes and their association with renal functionParsa, A.; Fuchsberger, C.; Köttgen, A.; O'Seaghdha, C.; Pattaro, C.; De Andrade, M.; Chasman, D.; Teumer, A.; Endlich, K.; Olden, M.; Chen, M.; Tin, A.; Kim, Y.; Taliun, D.; Li, M.; Feitosa, M.; Gorski, M.; Yang, Q.; Hundertmark, C.; Foster, M.; et al.
2013A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemiasCortes, J.E.; Kim, D.W.; Pinilla-Ibarz, J.; Le Coutre, P.; Paquette, R.; Chuah, C.; Nicolini, F.E.; Apperley, J.F.; Khoury, H.J.; Talpaz, M.; DiPersio, J.; DeAngelo, D.J.; Abruzzese, E.; Rea, D.; Baccarani, M.; Müller, M.C.; Gambacorti-Passerini, C.; Wong, S.; Lustgarten, S.; Rivera, V.M.; et al.
2013A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinsons diseaseHolmans, P.; Moskvina, V.; Jones, L.; Sharma, M.; Vedernikov, A.; Buchel, F.; Sadd, M.; Bras, J.M.; Bettella, F.; Nicolaou, N.; Simon-Sanchez, J.; Mittag, F.; Gibbs, J.R.; Schulte, C.; Durr, A.; Guerreiro, R.; Hernandez, D.; Brice, A.; Stefansson, H.; Majamaa, K.; et al.
2013The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphismKlebe, S.; Golmard, J.-L.; Nalls, M.A.; Saad, M.; Singleton, A.B.; Bras, J.M.; Hardy, J.; Simon-Sanchez, J.; Heutink, P.; Kuhlenbaeumer, G.; Charfi, R.; Klein, C.; Hagenah, J.; Gasser, T.; Wurster, I.; Lesage, S.; Lorenz, D.; Deuschl, G.; Durif, F.; Pollak, P.; et al.
2013A novel prion disease associated with diarrhea and autonomic neuropathyMead, S.; Gandhi, S.; Beck, J.; Caine, D.; Gallujipali, D.; Carswell, C.; Hyare, H.; Joiner, S.; Ayling, H.; Lashley, T.; Linehan, J.M.; Al-Doujaily, H.; Sharps, B.; Revesz, T.; Sandberg, M.K.; Reilly, M.M.; Koltzenburg, M.; Forbes, A.; Rudge, P.; Brandner, S.; et al.
2013Gene-centric meta-analyses of 108 912 individuals confirm known body mass index loci and reveal three novel signalsGuo, Y.; Lanktree, M.; Taylor, K.; Hakonarson, H.; Lange, L.; Keating, B.; Guo, Y.; Taylor, K.; Fairfax, B.; Elbers, C.; Barnard, J.; Farrall, M.; Padmanabhan, S.; Baumert, J.; Castillo, B.; Gaunt, T.; Gong, Y.; Rajagopalan, R.; Romaine, S.; Kumari, M.; et al.
2013Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcriptionThomas, D.; Powell, J.; Vergez, F.; Segal, D.; Nguyen, N.; Baker, A.; Teh, T.; Barry, E.; Sarry, J.; Lee, E.; Nero, T.; Jabbour, A.; Giovanna, P.; Green, B.; Manenti, S.; Glaser, S.; Parker, M.; Lopez, A.; Ekert, P.; Lock, R.; et al.
2013PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancerDay, F.; Jorissen, R.; Lipton, L.; Mouradov, D.; Sakthianandeswaren, A.; Christie, M.; Li, S.; Tsui, C.; Tie, J.; Desai, J.; Xu, Z.; Molloy, P.; Whitehall, V.; Leggett, B.; Jones, I.; McLaughlin, S.; Ward, R.; Hawkins, N.; Ruszkiewicz, A.; Moore, J.; et al.
2013Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: The NCIC clinical trials group and AGITG co.Siu, L.; Shapiro, J.; Jonker, D.; Karapetis, C.; Zalcberg, J.; Simes, J.; Couture, F.; Moore, M.; Price, T.; Siddiqui, J.; Nott, L.; Charpentier, D.; Liauw, W.; Sawyer, M.; Jefford, M.; Magoski, N.; Haydon, A.; Walters, I.; Ringash, J.; Tu, D.; et al.
2013Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27Young, J.; Ting, K.; Li, J.; Moller, T.; Dunn, L.; Lu, Y.; Moses, J.; Prado-Lourenco, L.; Khachigian, L.; Ng, M.; Gregory, P.; Goodall, G.; Tsykin, A.; Lichtenstein, I.; Hahn, C.; Tran, N.; Shackel, N.; Kench, J.; McCaughan, G.; Vadas, M.; et al.

Discover